PS PeptideSuppliers.org Finding the right peptide supplier for you
PT-141 / Bremelanotide reference image
View supplier listing 10% off with code IRONMAN
Peptide guide

PT-141 / Bremelanotide Peptide Guide & Supplier Listing Notes

Bremelanotide; melanocortin receptor agonist peptide

Melanocortin receptor peptide with approved-drug context

Immune and regulatory research compounds Educational guide Supplier transparency
Back to directory Compare supplier pages

Research Areas

The main research domains where this compound appears most often.

The main research area for PT-141 is sexual-function research. Studies have evaluated subjective arousal, desire-related outcomes, and central melanocortin signaling.

A second research area is melanocortin receptor pharmacology. PT-141 helps illustrate how MC3R and MC4R pathways can influence behavior and arousal.

PT-141 is also relevant to peptide-drug development because bremelanotide moved from peptide research into an approved medication context. This makes it a useful example of how a peptide-derived compound can enter formal clinical use.

Animal studies

What preclinical work has emphasized

Animal research on melanocortin signaling helped establish the role of melanocortin receptors in sexual behavior and central nervous system regulation. These studies provided mechanistic rationale for PT-141 development.

Animal findings help explain receptor pathways, but human clinical data is more important for understanding PT-141's current research profile.

Human studies

How much human evidence exists

PT-141 has human clinical research. Early studies evaluated intranasal PT-141 in male sexual-function settings. Later studies and reviews describe bremelanotide as a melanocortin receptor agonist evaluated for female hypoactive sexual desire disorder.

Because bremelanotide has a defined approved-drug context, precision matters. Supplier products in this category should not be treated as equivalent to regulated medication, and the scientific overview should stay focused on the published literature while preserving research-use boundaries.

Current research status

Where the research stands now

PT-141 is best understood as a melanocortin receptor agonist with a substantial human research history and an approved-drug identity as bremelanotide in a defined indication. Current research interest centers on central arousal pathways, melanocortin receptor biology, and sexual-function outcomes.

For a supplier directory, the most important task is to maintain a clinical, non-sensational tone.

Browse suppliers Open peptide directory Read education guides Best peptide suppliers

Related Compounds

Closely related compounds frequently discussed within the same research category.

Melanotan II is related because both are melanocortin analogs. Alpha-MSH is related as the biological peptide background. Other melanocortin receptor ligands are related through receptor pharmacology.

Melanotan II Kisspeptin-10
Supplier considerations

How to read supplier pages more carefully

PT-141 listings should clearly identify the compound as PT-141 or bremelanotide and should include batch-specific COAs, purity testing, lot numbers, and storage guidance. Because PT-141 overlaps with regulated-drug discussions, supplier pages should avoid treatment claims and keep research-use labeling clear.

  • Look for batch-specific COAs instead of generic laboratory files reused across many listings.
  • Check whether the product name, concentration language, and batch references stay consistent from page to page.
  • Read storage and handling notes alongside the document links rather than treating the headline purity claim as enough.
  • Prefer supplier pages that keep research-use labeling, contact details, and policy pages easy to verify.

Linked supplier pages

Supplier pages that help compare naming, documentation access, batch references, and overall page clarity.

Supplier listing

Iron Peptides

This listing helps with checking naming, documentation access, storage language, and overall page clarity.

View supplier listing
10% off with code IRONMAN

Frequently Asked Questions

Common questions drawn from the published literature and documentation context.

What is PT-141?

PT-141, or bremelanotide, is a melanocortin receptor agonist studied in sexual-function research.

Is PT-141 the same as bremelanotide?

PT-141 is commonly referred to as bremelanotide.

How does PT-141 work?

It acts through melanocortin receptors, especially central nervous system pathways involving MC3R and MC4R.

Is PT-141 like sildenafil?

No. Sildenafil works through vascular PDE5 inhibition, while PT-141 acts through melanocortin signaling.

Does PT-141 have human research?

Yes. PT-141/bremelanotide has human clinical research.

What compounds are related to PT-141?

Melanotan II, alpha-MSH, and other melanocortin analogs are related.

Why should PT-141 pages use a careful tone?

Because the topic overlaps with sexual health and approved-drug contexts, claims must be precise and non-sensational.

What should researchers check when comparing suppliers?

COAs, identity testing, purity, lot number, storage guidance, and research-use labeling.

References

Primary sources and clinical references cited in this overview.